These results, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the thought of focusing on ACKR3 as a unique strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders. The nutritional supplement is built utili